TMCnet News

Label-Free Detection Market - Drug Discovery Programs in the Americas to Boost Sales | Technavio
[October 19, 2017]

Label-Free Detection Market - Drug Discovery Programs in the Americas to Boost Sales | Technavio


The global label-free detection (LFD) market is expected to grow at an impressive CAGR of close to 11% during the forecast period, according to Technavio's latest market research.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171019006025/en/

Technavio has published a new report on the global label-free detection (LFD) market from 2017-2021. ...

Technavio has published a new report on the global label-free detection (LFD) market from 2017-2021. (Graphic: Business Wire)

In this market research report, Technavio covers the market outlook and growth prospects of the global label-free detection (LFD) market for 2017-2021. The market is further categorized into products (cell-based assays and biochemical assays) and end-user (pharmaceutical and biotechnology companies, contract research organizations (CROs), and academic and research institutes).

Technavio's research analysts segment the global label-free detection (LFD) market into the following regions:

  • Americas
  • APAC
  • EMEA

Looking for more information on this market? Request a free sample report

Technavio's sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.

Americas: largest LFD market

The rise in chronic diseases such as cancer, autoimmune diseases, and other life-threatening diseases are leading to an increase in drug discovery programs in the Americas. The various drug discovery campaigns and conferences are organized to help increase market funding. The rising number of collaborations among pharma companies and academic institutes will fuel the development of the LFD market in the Americas. The improvement in economc conditions and healthcare services in countries such as Brazil and Mexico will have a positive impact on the market. In 2016, the Americas accounted for around 45% of the total market share.



"The partnerships between academic institutes and industry giants helps reduce the clinical trial cost and testing of efficacy through LFD technology. The US, Mexico, and Canada are some of the major LFD markets in the Americas with the US being the highest contributor. The market in the US is dominated by the presence of major vendors. Drug discovery programs and conferences help in accelerating biomedical research in the country," says Srinivas Sashidhar, a lead research expert from Technavio for life science research tools.

This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing


Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

EMEA

The LFD market in EMEA occupied about 34% of the total market share in 2016. The rise in chronic diseases is leading to an increase in the development of personalized medicine, which enhances the treatment process and controls the mortality rate in the region. The LFD market in EMEA is also witnessing a fast-paced growth in Eastern European and African countries such as Tanzania, Algeria, and Ethiopia.

"Governments in different countries in Europe are looking for alternatives to centralize testing procedures and are encouraging diagnostic centers to adhere to a single regulatory environment. With vendors paying close attention to LFD applications required, new end-user bases such as Contract Research Organizations are set up," says Srinivas.

APAC

In 2016, the LFD market in APAC accounted for around 21% of the total market share. The increase in outsourcing activities to CROs by leading pharmaceutical to the emerging nations in APAC will boost the development in the region. India and China are lucrative markets for drug enhancement, kinetic studies, and outsourcing to CROs by biopharmaceutical companies. The increasing patient pool, growing interest of international players such as Bio-Rad Laboratories and F. Hoffmann-La Roche, and increasing R&D activities are propelling the market growth in this region.

The top vendors in the global label-free detection (LFD) market as highlighted in this market research analysis are:

  • Bio-Rad Laboratories
  • GE Healthcare
  • F.Hoffman (News - Alert)-La Roche

Browse Related Reports:

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at [email protected].


[ Back To TMCnet.com's Homepage ]